title: Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients.
abstract: Hepatitis E virus (HEV) can chronically infect immunocompromised patients. The polyproline region (PPR) and the macro domain of ORF1 protein may modulate virus production and/or the host immune response. We investigated the association between the genetic heterogeneity of HEV quasispecies in ORF1 and the outcome of infection in solid-organ transplant patients. Both sequence entropy and genetic distances during the hepatitis E acute phase were higher in patients whose infection became chronic than in those who cleared the virus. Hence, great quasispecies heterogeneity in the regions encoding the PPR and the macro domain may facilitate HEV persistence.
authors: Centre de Physiopathologie de Toulouse Purpan, INSERM, U1043, Toulouse.
authors: Sebastien
authors: S
authors: Lhomme
authors: Cyril
authors: C
authors: Garrouste
authors: Nassim
authors: N
authors: Kamar
authors: Karine
authors: K
authors: Saune
authors: Florence
authors: F
authors: Abravanel
authors: Jean-Michel
authors: JM
authors: Mansuy
authors: Martine
authors: M
authors: Dubois
authors: Lionel
authors: L
authors: Rostaing
authors: Jacques
authors: J
authors: Izopet
mesh_terms: D000328:Adult; D002908:Chronic Disease; D005260:Female; D018740:Genetic Heterogeneity; D016751:Hepatitis E / Q000276:immunology* / Q000821:virology; D016752:Hepatitis E virus / Q000235:genetics / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D016377:Organ Transplantation / Q000009:adverse effects; D010455:Peptides / Q000235:genetics / Q000276:immunology; D014180:Transplantation; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology*
chemical_list: D010455:Peptides; D014764:Viral Proteins; C011083:polyproline
keywords: ORF1; chronic infection; hepatitis E; macro domain; polyproline region
references: J Clin Microbiol. 2012 Mar;50(3):897-902
references: 22205792
references: J Virol. 2005 Oct;79(20):12721-31
references: 16188975
references: PLoS One. 2012;7(4):e35974
references: 22545153
references: J Virol. 2008 Dec;82(24):12325-34
references: 18922871
references: Virus Res. 2011 Oct;161(1):47-58
references: 21345356
references: J Virol. 2012 Sep;86(18):10006-14
references: 22761386
references: J Gen Virol. 2013 Apr;94(Pt 4):807-816
references: 23255617
references: J Infect Dis. 2010 Sep 15;202(6):835-44
references: 20695798
references: J Gen Virol. 2010 Apr;91(Pt 4):1047-57
references: 19923257
references: N Engl J Med. 2008 Feb 21;358(8):811-7
references: 18287603
references: Trends Ecol Evol. 2000 Dec 1;15(12):496-503
references: 11114436
references: J Virol. 2009 Jan;83(1):384-95
references: 18945785
references: Science. 2000 Apr 14;288(5464):339-44
references: 10764648
references: Lancet. 2012 Jun 30;379(9835):2477-2488
references: 22549046
references: Emerg Infect Dis. 2009 Jan;15(1):110-4
references: 19116067